Arcutis Biotherapeutics Market Sentiment

Arcutis Biotherapeutics Inc

ARQTNASDAQ

$32.25

0.050.16%

Dern. MÀJ: Oct 23, 8:18 AM

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Résultats: Résultats Q3 2026 dans dans 12 jours à partir de maintenant le mer. nov. 4th, après la fermeture du marché

Arcutis Biotherapeutics Market Sentiment - Benzinga

Arcutis Biotherapeutics Market Sentiment

Market sentiment signals for Arcutis Biotherapeutics (ARQT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 18.4% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

12 analysts

Options Flow (P/C)

—

Avg Consensus PT

$31

-2.8%

Highest Price Target

$48

+48.8%

Cantor Fitzgerald

Lowest Price Target

-75.2%

HC Wainwright & Co.

Short Interest

18.4%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 19, 2026	Guggenheim	Seamus Fernandez—	+36.4%	$38 → $44	Maintained	Buy
Oct 15, 2026	Cantor Fitzgerald	Steve Seedhouse—	+48.8%	$48	Initiate	Overweight
Aug 6, 2026	Morgan Stanley	Vikram Purohit—	+17.8%	$34 → $38	Maintained	Overweight
Aug 6, 2026	Guggenheim	Seamus Fernandez—	+17.8%	$35 → $38	Maintained	Buy
Aug 6, 2026	Needham	Serge Belanger—	+24.0%	$36 → $40	Maintained	Buy
May 7, 2026	Needham	Serge Belanger—	+11.6%	$36 → $36	Maintained	Buy
Mar 2, 2026	Mizuho	Uy Ear—	+8.5%	$37 → $35	Maintained	Outperform
Feb 27, 2026	Guggenheim	Seamus Fernandez—	+8.5%	$34 → $35	Maintained	Buy
Feb 26, 2026	TD Cowen	Tyler Van Buren—	+8.5%	$30 → $35	Maintained	Buy
Feb 26, 2026	HC Wainwright & Co.	Douglas Tsao—	+5.4%	$30 → $34	Maintained	Buy
Feb 26, 2026	Needham	Serge Belanger—	+11.6%	$31 → $36	Maintained	Buy
Jan 26, 2026	Needham	Serge Belanger—	-3.9%	$30 → $31	Maintained	Buy
Nov 28, 2025	Mizuho	Uy Ear—	+14.7%	$32 → $37	Maintained	Outperform
Oct 30, 2025	Goldman Sachs	Richard Law—	-10.1%	$19 → $29	Maintained	Neutral
Oct 28, 2025	Needham	Serge Belanger—	-7.0%	$22 → $30	Maintained	Buy
Aug 7, 2025	Needham	Serge Belanger—	-31.8%	$20 → $22	Maintained	Buy
Jul 25, 2025	Goldman Sachs	Richard Law—	-44.2%	$18	Initiate	Neutral
May 23, 2025	Needham	Serge Belanger—	-38.0%	$20 → $20	Maintained	Buy
Apr 9, 2025	Needham	Serge Belanger—	-38.0%	$20 → $20	Maintained	Buy
Apr 3, 2025	Guggenheim	Seamus Fernandez—	—	—	Maintained	Buy
Apr 3, 2025	HC Wainwright & Co.	Douglas Tsao—	-41.1%	$19 → $19	Maintained	Buy
Apr 3, 2025	Needham	Serge Belanger—	-38.0%	$20 → $20	Maintained	Buy
Mar 11, 2025	Jefferies	Kambiz Yazdi—	-41.1%	$16 → $19	Maintained	Buy
Feb 27, 2025	Goldman Sachs	Jonathan Block—	-53.5%	$13 → $15	Maintained	Neutral
Feb 26, 2025	HC Wainwright & Co.	Douglas Tsao—	-41.1%	$19 → $19	Maintained	Buy